USPTO serial 97334275
NEXT TRILLION SCIENCES
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- ONUOHA, ALEXANDRIA N
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NEXT TRILLION SCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cleveland, OH, US
Cleveland, OH, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian E. Turung
Brian E. Turung ULMER & BERNE LLP1660 WEST 2ND STREETSKYLIGHT OFFICE TOWER, SUITE 1100CLEVELAND, OH 44113Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 016 | Printed reports, namely, printed scientific analysis and informational reports based upon results of laboratory and clinical testing in the field of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements | ACTIVE | — |
| 035 | Pre-clinical and clinical testing services for companies, medical professionals, namely, providing independent review of clinical trials for business purposes, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs | ACTIVE | — |
| 042 | Pre-clinical and clinical testing services for companies, medical professionals, namely, conducting clinical trials for others, consulting services for others in the field of design, planning, and implementation project management of clinical trials; consulting services for others in the field of design, planning, and implementation of project management for scientific research, clinical trials, and statistical analyses for research purposes in the field of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements; scientific research, namely, conducting pre-clinical trials and supporting clinical trials for others; providing scientific research information in the field of pre-clinical testing; medical and scientific research, namely, conducting clinical and pre-clinical trial services for others; providing scientific analysis in the field of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements;scientific study and research in the field of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements; scientific and technological services, namely, scientific analysis in the field of testing the human body | ACTIVE | — |
| 044 | Hospital services; providing healthcare consulting services in the fields of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements; Providing medical information retarding regarding available tests and the review of tests related to the infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements; providing medical information about the use of microorganisms to treat diseases and medical conditions in the digestive system; medical diagnosis of diseases and medical conditions in particular digestive disorders, speech disorders, breast cancer, infertility, mental health disorders, autoimmune diseases, learning disabilities;providing medical information, advice and consultation to others in the field of infections, dermatology, oncology, allergy and immunology, human microbiota, human microbiome, digestive system, medical genetics, neurology, obstetrics and gynecology, ophthalmology, pathology, preventive medicine, urology, human diet, dietary supplements, vitamin and nutrient supplements | ACTIVE | — |
| 045 | Pre-clinical and clinical testing services for companies, medical professionals, namely, providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NTS Ventures LLC
- Other trademarks owned by NTS Ventures LLC
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named NEXT TRILLION SCIENCES
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 24, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 24, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 14, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 13, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jul 13, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 23, 2026 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Apr 23, 2026 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Apr 23, 2026 | PETG | PETITION TO REVIVE-GRANTED | — |
| Apr 23, 2026 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Feb 23, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 23, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 20, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jul 11, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 10, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 10, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 10, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 22, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 21, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 21, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 24, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 18, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 18, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 18, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 19, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 17, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 17, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 17, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 18, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 23, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 23, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 17, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 17, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 1, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |